LC–MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Ciencias Forenses, Anatomía Patolóxica, Xinecoloxía e Obstetricia, e Pediatría
dc.contributor.authorLópez Rabuñal, Ángela
dc.contributor.authorLendoiro Belío, Elena
dc.contributor.authorConcheiro, M.
dc.contributor.authorLópez-Rivadulla Lamas, Manuel
dc.contributor.authorCruz Landeira, Angelines
dc.contributor.authorCastro Ríos, Ana de
dc.date.accessioned2025-01-18T09:57:46Z
dc.date.available2025-01-18T09:57:46Z
dc.date.issued2020
dc.description.abstractAn LC-MS-MS method for the determination of 14 benzodiazepines (BZDs) (alprazolam, α-hydroxyalprazolam, clonazepam, bromazepam, diazepam, nordiazepam, lorazepam, lormetazepam, oxazepam, flunitrazepam, 7-aminoflunitrazepam, triazolam, midazolam and zolpidem) and 15 antidepressants (ADs) (amitriptyline, nortriptyline, imipramine, desipramine, clomipramine, norclomipramine, fluoxetine, norfluoxetine, sertraline, norsertraline, paroxetine, venlafaxine, desmethylvenlafaxine, citalopram and desmethylcitalopram) in meconium was developed and validated. Meconium samples (0.25 ± 0.02 g) were homogenized in methanol and subjected to mixed-mode cation exchange solid-phase extraction. Chromatographic separation was performed in reversed phase, with a gradient of 0.1% formic acid in 2 mM ammonium formate and acetonitrile. Two different chromatographic gradient methods were employed, one for the separation of ADs and another for BZDs. Analytes were monitored by tandem mass spectrometry employing electrospray positive mode in MRM mode (2 transitions per compound). Method validation included: linearity [n = 5, limit of quantification (LOQ) to 400 ng/g], limits of detection (n = 6, 1-20 ng/g), LOQ (n = 9, 5-20 ng/g), selectivity (no endogenous or exogenous interferences), accuracy (n = 15, 90.6-111.5%), imprecision (n = 15, 0-14.6%), matrix effect (n = 10, -73 to 194.9%), extraction efficiency (n = 6, 35.9-91.2%), process efficiency (n = 6, 20.1-188.2%), stability 72 h in the autosampler (n = 3, -8.5 to 9%) and freeze/thaw stability (n = 3, -1.2 to -47%). The method was applied to four meconium specimens, which were analyzed with and without hydrolysis (enzymatic and alkaline). The authentic meconium samples tested positive for alprazolam, α-hydroxyalprazolam, clonazepam, diazepam, nordiazepam, fluoxetine, norfluoxetine, clomipramine and norclomipramine. Therefore, the present LC-MS-MS method allows a high throughput determination of the most common BZDs and ADs in meconium, which could be useful in clinical and forensic settings.
dc.description.peerreviewedSI
dc.identifier.citationLópez-Rabuñal, A., Lendoiro, E., Concheiro, M., López-Rivadulla, M., Cruz, A., & de-Castro-Ríos, A. (2020). LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium. Journal of analytical toxicology, 44(6), 580–588. https://doi.org/10.1093/jat/bkaa012
dc.identifier.doi10.1093/jat/bkaa012
dc.identifier.essn945-2403
dc.identifier.issn0146-4760
dc.identifier.urihttps://hdl.handle.net/10347/38672
dc.issue.number6
dc.language.isoeng
dc.page.final588
dc.page.initial580
dc.publisherOxford University Press
dc.rights.accessRightsopen access
dc.subjectAntidepressant
dc.subjectBenzodiazepine
dc.subjectPregnancy
dc.subjectMeconium
dc.subjectIn utero exposure
dc.subjectLC-MS/MS
dc.titleLC–MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium
dc.typejournal article
dc.type.hasVersionAM
dc.volume.number44
dspace.entity.typePublication
relation.isAuthorOfPublicationb19c766c-2fe8-4d0f-89c6-40b73a1ab3b3
relation.isAuthorOfPublicationbbe1bab3-19e8-4a4a-83f5-26549ecf0557
relation.isAuthorOfPublicationdf83fccc-7b97-459a-850b-f6783ab59440
relation.isAuthorOfPublicationc972b8db-3a4f-4de0-8379-2731ab2136fd
relation.isAuthorOfPublication.latestForDiscoveryb19c766c-2fe8-4d0f-89c6-40b73a1ab3b3

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LC-MS:MS METHOD FOR THE DETERMINATION OF ANTIDEPRESSANTS AND BENZODIAZEPINES IN MECONIUM_VERSION ACEPTADA.pdf
Size:
1.56 MB
Format:
Adobe Portable Document Format